Merus N.V. (MRUS)
NASDAQ: MRUS · Real-Time Price · USD
44.61
-0.22 (-0.49%)
At close: Mar 28, 2025, 4:00 PM
44.01
-0.60 (-1.34%)
After-hours: Mar 28, 2025, 5:31 PM EDT
Merus Market Cap
Merus has a market cap or net worth of $3.08 billion as of March 28, 2025. Its market cap has increased by 17.50% in one year.
Market Cap
3.08B
Enterprise Value
2.37B
1-Year Change
17.50%
Ranking
Category
Stock Price
$44.61
Market Cap Chart
Since May 19, 2016, Merus's market cap has increased from $143.00M to $3.08B, an increase of 2,055.33%. That is a compound annual growth rate of 41.40%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 28, 2025 | 3.08B | 7.06% |
| Dec 31, 2024 | 2.88B | 81.33% |
| Dec 29, 2023 | 1.59B | 121.65% |
| Dec 30, 2022 | 716.30M | -41.96% |
| Dec 31, 2021 | 1.23B | 142.03% |
| Dec 31, 2020 | 509.90M | 55.03% |
| Dec 31, 2019 | 328.90M | 20.92% |
| Dec 31, 2018 | 272.00M | -12.85% |
| Dec 29, 2017 | 312.10M | 3.83% |
| Dec 30, 2016 | 300.60M | 110.21% |
View and export this data all the way back to 2016.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 738.73B |
| UnitedHealth Group | 475.64B |
| Johnson & Johnson | 395.20B |
| AbbVie | 357.36B |
| Novo Nordisk | 308.71B |
| Abbott Laboratories | 227.96B |
| Merck & Co. | 225.21B |
| AstraZeneca | 225.00B |